HemOnc Today Current Issue
The following articles appeared in the print edition of HemOnc Today.
Table of Contents
- Field of cardio-oncology opens new pathways for consultation, collaboration
-
- 20 educators chosen for ASH institute
- Association gives service award
- COLUMBUS trial: Binimetinib plus encorafenib improves PFS in BRAF–mutant melanoma
- Community oncologist receives national award
- Foundation makes two appointments
- Juno Therapeutics places voluntary hold on CAR T-cell trial after patient deaths
- Lung cancer foundation honors City of Hope department chair
- National Academy of Medicine elects 79 new members
-
- Nurses receive leadership awards
- NYU Langone names chief of hematology, medical oncology
- Phase 3 trial shows Opdivo improves OS in patients with gastric cancer
- Rutgers Cancer Institute of New Jersey names new director
- V Foundation presents grants to Vanderbilt researchers
- Big gains in oncology may be offset if banks move toward another cliff Derek Raghavan, MD, PhD, FACP, FRACP, FASCO
- FDA approves Darzalex plus two standard-of-care regimens for multiple myeloma
- FDA approves Opdivo for recurrent or metastatic HNSCC
-
- FDA grants breakthrough therapy designation to Adcetris for common CTCL subtypes
- FDA grants fast track designation to tazemetostat for diffuse large B-cell lymphoma
- FDA grants full approval to Iclusig for CML, Ph+ALL
- FDA grants orphan drug, fast track designations to AM0010 for treatment of pancreatic cancer
- FDA grants priority review to Keytruda for microsatellite instability–high cancers
- FDA grants priority review to LEE011 as part of first-line combination for advanced breast cancer
- FDA grants priority review to midostaurin for FLT3–mutated AML, advanced systemic mastocytosis
- Bankruptcy increases risk for cancer mortality
-
- Cetuximab benefits patients with oropharyngeal cancer, regardless of HPV, p16 status
- Colorectal cancer incidence rising in patients younger than screening age
- Earlier hospice, avoidance of ICU improve family members’ perceptions of end-of-life care
- Environmental, genetic factors may predict longevity in sickle cell disease
- Experts: Cancer drug waste costs $2.8 billion annually in the U.S.
- Extramedullary disease not prognostic for survival in AML
- Genetic data improves survival prediction in patients with NSCLC, brain metastases
- Haploidentical HSCT reduces risk for chronic GVHD among patients with lymphoma
-
- Incidence of anal cancer rising worldwide
- Multiple mental health symptoms common in adolescent cancer survivors
- Obesity rates rising faster in cancer survivors than in general population
- Patient age, DCIS status predict ipsilateral breast tumor recurrence
- Refocusing public narrative necessary to raise ‘alarmingly low’ HPV vaccination rates
- Rivaroxaban may effectively treat heparin-induced thrombocytopenia
- Specialized melanoma surveillance strategy yields lower costs, fewer excisions
- Task force: Evidence insufficient to recommend skin cancer screening
-
- Urine gene expression assay may noninvasively diagnose prostate cancer
- Vasectomy does not increase risk for prostate cancer incidence, mortality
- Treatment reduces malaria incidence via blood transfusion in Ghana
- Addition of capecitabine to adjuvant chemotherapy extends survival in pancreatic cancer
- Anti–CD22 CAR T-cell therapy induces responses in relapsed, refractory ALL
- Cabozantinib extends PFS in metastatic renal cell carcinoma
- Chemoradiation improves OS, PFS in older patients with glioblastoma
- CPX-351 effectively provides bridge to transplantation in poor-risk AML
-
- Daratumumab associated with deep clinical response in relapsed, refractory multiple myeloma
- Encapsulated Factor VIII shows promise for hemophilia A with inhibitors
- Everolimus–fulvestrant combination extends PFS in certain postmenopausal women with breast cancer
- Extended letrozole provides no significant benefit in subset of postmenopausal women with breast cancer
- Extent of thyroid surgery often miscoded in cancer registries
- Hydroxyurea therapy feasible for primary stroke prevention in Nigerian children with sickle cell anemia
- Intraperitoneal chemotherapy after ovarian cancer surgery slows disease progression
- Liquid biopsy assay exhibits efficacy similar to traditional tumor biopsy
-
- Multidisciplinary approach for pregnant women with sickle cell disease reduces maternal, perinatal mortality
- Mutational landscape in ER–positive breast cancer varies between primary tumor, metastatic disease
- Oral vancomycin prevents C. difficile infection in allogeneic HSCT recipients
- Pembrolizumab extends survival in advanced, PD-L1–positive NSCLC
- Vadastuximab talirine appears safe, effective when combined with 7 + 3 chemotherapy for AML induction
- Veliparib fails to significantly extend survival in BRCA–mutated locally recurrent or metastatic breast cancer